• June 13, 2022

    Tchaikapharma has expanded its portfolio with another product, namely Fluidoro 10 mg film-coated tablets (with active ingredient prasugrel). It belongs to a group of drugs called platelet antiaggregants – it inhibits the accumulation of platelets and thus reduces the risk of blood clots.   Fluidoro, given concomitantly with acetylsalicylic acid (ASA), is indicated for the […]

  • May 20, 2022

    Tchaikapharma’s product portfolio was presented at the 6th congress of the Society of Cardiologists of Kosovo under the auspices of the European Society of Cardiology. Тhe company’s top products Tamaira, Co-Telsart, Amariton and Rosta were of particular interest as the preferred choice of the cardiologists in the country. This is one of the reasons why […]

  • April 4, 2022

      The pandemic has caused problems in the forefront of predictability and access to medicines in the country. It was difficult to supply the basic (active) substances for pharmaceutical production, and a slight increase in the production of drugs.   In this context, even before the first global lockdown, the team of Tchaikapharma has prepared […]

  • April 1, 2022

    The first humanitarian aid from Pleven is already on its way to the twin city of Nikolayev, expected to arrive tomorrow at noon. The main donation consists of antiviral preparations, sleeping bags, external batteries for charging mobile phones, backpacks, lanterns – these were the requests of the local government in Nikolaev. The medicines were provided […]

  • March 15, 2022

    2021 was a very successful year for the manufacturing facilities of Tchaikapharma High Quality Medicines in Plovdiv and Varna. Numerous improvements related to the modernization of the manufactiring process were introduced at the company’s plant in Plovdiv: – a Production Permit was obtained for a new granulation room in the tablet manufacturing facility, doubling the […]